Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1217428

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1217428

Stem Cell Therapy Global Market Report 2023

Published: Pre-Order
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

“Stem Cell Therapy Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The stem cell therapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Allogeneic Stem Cell Therapy; Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells; Induced Pluripotent Stem Cells; Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders; Wounds and Injuries; Cancer; Autoimmune Disorders; Other Applications

4) By End-User: Hospitals; Clinics

Companies Mentioned: Anterogen; JCR Pharmaceuticals; Medipost; Osiris Therapeutics; Pharmicell

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the stem cell therapy market are: Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, ReNeuron Group, Takeda Pharmaceuticals, Magellan, Kolon TissueGene, Stemedica Cell Technologies, Holostem Terapie Avanzate S.r.l., NuVasive, RTI Surgical and AlloSource.

The global stem cell therapy market will grow from $5.14 billion in 2022 to $6.45 billion in 2023 at a compound annual growth rate (CAGR) of 25.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The stem cell therapy market is expected to grow to $11.88 billion in 2027 at a CAGR of 16.5%.

The stem cell therapy market includes revenues earned by entities by hematopoietic stem cells, skin stem cells, neural stem cells, and mesenchymal stem cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Stem cell therapy refers to a form of regenerative medicine that uses stem cells or their byproducts to stimulate the body's natural repair process in damaged, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs-which are scarce-with cells.

North America was the largest region in the stem cell therapy market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of stem cell therapy are allogeneic stem cell therapy and autologous stem cell therapy. Allogeneic stem cell transplantation involves transferring stem cells from a healthy person (the donor) to the patient's body after high-intensity chemotherapy or radiation, The various sources of the cells include adult stem cells; induced pluripotent stem cells, and embryonic stem cells that are used for the treatment of musculoskeletal disorders; wounds and injuries; cancer; autoimmune disorders and others. The therapies are used by hospitals and clinics.

The rising prevalence of chronic diseases contributed to the growth of the stem cell therapy market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases among people, thus driving the need for stem cell therapy. According to a United Nations article, by 2030, the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic diseases is expected to reach about 60%. The rising prevalence of chronic diseases is expected to drive the stem cell therapy market.

The high cost of stem cell therapy is expected to limit the growth of the stem cell therapy market. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for chronic diseases has impacted the health conditions of the population and has led to a low average life expectancy. According to the DVCSTEM, the average cost of stem cell therapy in the USA is between $20,000 to $25,000, in Mexico, it is $33,000, in Central America, it is $30,000, and in Asia, it is $50,000, thus restraining the growth of the market.

The companies in the stem cell therapy market are increasingly investing in strategic partnerships. A strategic partnership is a mutually beneficial agreement between two companies that do not compete directly with each other. For instance, in June 2020, Shanghai Cell Therapy Group (SHCell) has recently begun a six-year research collaboration with Professor Qi-Long Ying of the University of Southern California (USC). The Ying laboratory hopes to develop conditions for long-term ex vivo expansion of mouse and human hematopoietic stem and progenitor cells through the project, which is supported by $3.6 million from the Baize Plan Fund.

In July 2020, Boehringer Ingelheim, a Germany-based pharmaceutical company, acquired Global Stem cell Technology (GST) for an undisclosed amount. The acquisition completely supports Boehringer Ingelheim's Animal Health strategy, which aims to improve its portfolio capabilities to spur innovation and growth. The purchase comes after a two-year, fruitful relationship that saw the introduction of the first-ever registered stem cell-based veterinary treatment to the European market. GST is a Belgian biotech company that develops and produces state-of-the art stem cell products for horses and pets.

The countries covered in the stem cell therapy market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides stem cell therapy market statistics, including stem cell therapy industry global market size, regional shares, competitors with a stem cell therapy market share, detailed stem cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy industry. This stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Product Code: r2536

Table of Contents

1. Executive Summary

2. Stem Cell Therapy Market Characteristics

3. Stem Cell Therapy Market Trends And Strategies

4. Stem Cell Therapy Market - Macro Economic Scenario

4.1 COVID-19 Impact On Stem Cell Therapy Market

4.2 Ukraine-Russia War Impact On Stem Cell Therapy Market

4.3 Impact Of High Inflation On Stem Cell Therapy Market

5. Stem Cell Therapy Market Size And Growth

  • 5.1. Global Stem Cell Therapy Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Stem Cell Therapy Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Stem Cell Therapy Market Segmentation

  • 6.1. Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Allogeneic Stem Cell Therapy
  • Autologous Stem Cell Therapy
  • 6.2. Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Embryonic Stem Cells
  • 6.3. Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cancer
  • Autoimmune Disorders
  • Other Applications
  • 6.4. Global Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals

7. Stem Cell Therapy Market Regional And Country Analysis

  • 7.1. Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Stem Cell Therapy Market

  • 8.1. Asia-Pacific Stem Cell Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Stem Cell Therapy Market

  • 9.1. China Stem Cell Therapy Market Overview
  • 9.2. China Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Stem Cell Therapy Market

  • 10.1. India Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Stem Cell Therapy Market

  • 11.1. Japan Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Stem Cell Therapy Market

  • 12.1. Australia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Stem Cell Therapy Market

  • 13.1. Indonesia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Stem Cell Therapy Market

  • 14.1. South Korea Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Stem Cell Therapy Market

  • 15.1. Western Europe Stem Cell Therapy Market Overview
  • 15.2. Western Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Stem Cell Therapy Market

  • 16.1. UK Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Stem Cell Therapy Market

  • 17.1. Germany Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Stem Cell Therapy Market

  • 18.1. France Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Stem Cell Therapy Market

  • 19.1. Eastern Europe Stem Cell Therapy Market Overview
  • 19.2. Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Stem Cell Therapy Market

  • 20.1. Russia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Stem Cell Therapy Market

  • 21.1. North America Stem Cell Therapy Market Overview
  • 21.2. North America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Stem Cell Therapy Market

  • 22.1. USA Stem Cell Therapy Market Overview
  • 22.2. USA Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Stem Cell Therapy Market

  • 23.1. South America Stem Cell Therapy Market Overview
  • 23.2. South America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Stem Cell Therapy Market

  • 24.1. Brazil Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Stem Cell Therapy Market

  • 25.1. Middle East Stem Cell Therapy Market Overview
  • 25.2. Middle East Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Stem Cell Therapy Market

  • 26.1. Africa Stem Cell Therapy Market Overview
  • 26.2. Africa Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Stem Cell Therapy Market Competitive Landscape And Company Profiles

  • 27.1. Stem Cell Therapy Market Competitive Landscape
  • 27.2. Stem Cell Therapy Market Company Profiles
    • 27.2.1. Anterogen
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. JCR Pharmaceuticals
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Medipost
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Osiris Therapeutics
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Pharmicell
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Stem Cell Therapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Stem Cell Therapy Market

30. Stem Cell Therapy Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Historic And Forecast Inflation Rates
  • 31.4. Research Inquiries
  • 31.5. The Business Research Company
  • 31.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!